Attruby
Payments companies reported to CMS as associated with Attruby. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Attruby, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Attruby
These are the largest totals companies reported as associated with Attruby. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Dmitry Yaranov | Memphis, TN | Advanced Heart Failure and Transplant Cardiology | $79,948.06 |
| Albert Hicks | Temple, TX | Advanced Heart Failure and Transplant Cardiology | $75,581.36 |
| Vasvi Singh | Overland Park, KS | Cardiovascular Disease | $72,672.20 |
| Sabahat Bokhari | Allentown, PA | Cardiovascular Disease | $65,357.32 |
| David Hinchman | Boise, ID | Cardiovascular Disease | $50,979.46 |
| Marcus Urey | San Diego, CA | Advanced Heart Failure and Transplant Cardiology | $44,004.59 |
| Kunjan Bhatt | Austin, TX | Advanced Heart Failure and Transplant Cardiology | $42,050.35 |
| Aasim Afzal | Plano, TX | Advanced Heart Failure and Transplant Cardiology | $38,820.19 |
| David Wolinsky | Weston, FL | Cardiovascular Disease | $35,414.56 |
| Benjamin Horn | North Easton, MA | Cardiovascular Disease | $33,976.53 |
Prescribed Attruby?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.